Skip to main content
logo

Alvotech (ICE:ALVO)

Iceland flag Iceland · Delayed Price · Currency is ISK
1,130.00
-20.00 (-1.74%)
At close: Aug 1, 2025

Verve Therapeutics Revenue

Alvotech had revenue of $132.81M USD in the quarter ending March 31, 2025, with 259.97% growth. This brings the company's revenue in the last twelve months to $587.89M, up 413.92% year-over-year. In the year 2024, Alvotech had annual revenue of $491.98M with 426.84% growth.

Revenue (ttm)
$587.89M
Revenue Growth
+413.92%
P/S Ratio
4.39
Revenue / Employee
$580.92K
Employees
1,012
Market Cap
340.57B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024491.98M398.60M426.84%
Dec 31, 202393.38M8.37M9.84%
Dec 31, 202285.02M45.33M114.23%
Dec 31, 202139.68M-29.77M-42.86%
Dec 31, 202069.45M-13.23M-16.00%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Marel250.20B
Íslandsbanki62.96B
Arion banki61.68B
Sildarvinnslan Hf.43.52B
Brim hf.58.07B
Hagar177.12B
Kvika banki15.14B
Festi147.75B
Revenue Rankings

Alvotech News

More News